American Fusion Restructures Up to $2.88 Million of

New Post Public Reply Private Reply Replies (0) Message Board
louied91
57
American Fusion Restructures Up to $2.88 Million of Stock-Based Compensation Obligations into Long-Term, Lock-Up Preferred Equity and Begins Auditor Transition to MBP Global LLP

https://www.globenewswire.com/news-release/20...l-llp.html

SOUTHLAKE, Texas, Oct. 07, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTCQB: AMFN) (“American Fusion” or the “Company”), developer of the proprietary Texatron™ Fusion Engine™, today announced agreements to restructure existing stock-based compensation rights with an aggregate maximum contractual amount of $2.88 million into Series C Convertible Preferred Stock. The exchange is part of the Company’s broader capital restructuring effort in support of its planned national securities exchange listing and institutional financing initiatives.

Preferred Equity Exchange

The agreements cover twelve officers, directors, consultants and advisors, each with an existing contractual compensation basis of $240,000. They provide for issuance of up to 288,000 Series C preferred shares in total, subject to the applicable earning and exchange provisions. The exchange involves no cash payment by either party.

The Series C structure establishes defined conversion eligibility and quarterly limits for shares issued in connection with these compensation arrangements. The $2.88 million represents the maximum contractual compensation covered by the agreements, rather than a stated reduction in recorded liabilities. The amounts recognized in the Company’s financial statements and the resulting balance-sheet effect remain subject to accounting review.

“This restructuring brings greater clarity to our compensation commitments and establishes a defined schedule for conversion into common stock,” said Brent Nelson, Executive Chairman of American Fusion. “We appreciate the support of our team and advisors as we organize our capital structure and advance our financing and planned uplisting initiatives.”

Conversion Timing and Capital Structure

Conversions may begin in the first full calendar quarter following the later of full vesting under the underlying compensation agreement and the earlier of the twentieth trading day after a national securities exchange listing or nine months after the original issue date. Once eligible, holders may convert up to 30% of their original entitlement in each of the first three quarters, with the remaining balance eligible in the fourth quarter. Unused quarterly allowances do not carry forward. These provisions regulate conversion timing and are not a blanket prohibition on transfers.

Each Series C share is initially convertible into one common share, subject to adjustments under the Certificate of Designation. Conversion is also subject to a beneficial ownership limitation initially set at 4.99%, which a holder may increase to no more than 9.99% on at least 61 days’ notice. The certificate separately limits voting on an as-converted basis to 4.99%.

The preferred shares’ $10 face value is a contractual term, not a forecast or guarantee of the common stock’s trading price. Future restructuring events are subject to the adjustment provisions in the governing documents; other changes require the applicable approvals and amendments. Holders have no right to require redemption. The Company has a limited option to repurchase the preferred shares at 125% of face value before the earlier of a national exchange listing or nine months after the original issue date.

The exchange agreements specify September 30, 2026 as their effective date.

Auditor Transition

JV CPA Inc., a boutique Houston-based firm, resigned as American Fusion's independent registered public accounting firm effective October 1, 2026, citing health reasons. The Company's Item 4.01 disclosure states that there were no disagreements with JV CPA on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, and no reportable events, during the periods covered. JV CPA's letter to the SEC confirms its agreement with those statements.

The Company is in the process of engaging MBP Global LLP, a PCAOB-registered firm with over 40 years of operating history and extensive experience serving public companies, as its successor auditor. MBP Global would audit the Company's consolidated financial statements for the year ending December 31, 2026 and review its interim financial statements for the quarter ended September 30, 2026. MBP Global's client acceptance and onboarding procedures are underway. The engagement remains subject to completion of those procedures, and MBP Global has not yet formally accepted the engagement.

“We're prioritizing the information and coordination MBP Global needs to complete its acceptance process and begin the interim review,” said Brent Nelson, Executive Chairman. “As our operations grow more complex, strong and timely financial reporting is central to preparing for institutional financing and a planned exchange listing.”

Additional details are available in the Company's Current Report on Form 8-K filed October 6, 2026, and its exhibits.

American Fusion Inc (AMFN) Stock Research Links

AMFN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 276

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Governor Advocates for Controlled Substances Decriminalization

Updated Category News Views 48

Governor Advocates for Controlled Substances Decriminalization Puerto Rico’s Governor Pedro Pierluisi Urrutia has made a compelling argument for decriminalizing the consumption of all controlled substances. His stance primarily addresses the pressing fentanyl crisis affecting communities across the island. Governor Pierluisi highlighted, "I have said since the 90s that...

Continue Reading
Odyssey Marine Exploration: Navigating Stock Market Challenges

Updated Category News Views 221

Recent Trends in Odyssey Marine Exploration Stock Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) has seen its stock price fluctuate significantly in recent times. After an arbitration award involving the company and the United Mexican States was announced, the stock experienced a sharp decline, which has sparked concerns about its future path. Decoding the Arbitration...

Continue Reading
Decent Holding Inc. Unveils US$8 Million Offering for Growth

Updated Category News Views 101

Decent Holding Inc. Announced Its New Offering In a significant move within the wastewater treatment sector, Decent Holding Inc. (NASDAQ: DXST) shared exciting news about their latest financing initiative. The company has introduced a registered offering amounting to US$8 million. This offering involves 13,333,333 Class A ordinary shares priced at US$0.60 each, along with...

Continue Reading
Nexxen Strengthens Data Strategies with Eric Solomon's Leadership

Updated Category News Views 208

Nexxen Appoints Eric Solomon to Drive Data Strategy In a significant move for the advertising technology landscape, Nexxen (NASDAQ: NEXN) has welcomed Eric Solomon as its new Senior Vice President for Product – Data. This appointment underscores Nexxen's dedication to a data-driven approach that aims to enhance growth and success for advertisers and media companies...

Continue Reading